Geron
GERN
$4.08
Share price
3.82%
Change (1 day)
59.38%
Change (1 year)
Categories
Geron (GERN) - Total debt
Total debt on the balance sheet as of December 2023 : $85.89 M
According to Geron's latest financial reports the company's total debt is $85.89 M. A company’s total debt is the sum of all current and non-current debts.
Geron - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $85.89 M | 54.07% |
| 2022-12-31 | $55.75 M | 1.37% |
| 2021-12-31 | $54.99 M | 85.06% |
| 2020-12-31 | $29.71 M | 1063.63% |
| 2019-12-31 | $2.55 M | |
| 2018-12-31 | $N/A | |
| 2005-12-31 | $0.05 M | -98.31% |
| 2004-12-31 | $3.24 M | -47.59% |
| 2003-12-31 | $6.19 M | -76.21% |
| 2002-12-31 | $26.02 M | 49.39% |
| 2001-12-31 | $17.41 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $24.98 B | 28,988.81% | 🇺🇸 USA |
 Incyte INCY | $38.28 M | -55.43% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $48.89 M | -43.08% | 🇺🇸 USA |
 Bio-Techne TECH | $0.55 B | 546.92% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $41.84 M | -51.29% | 🇺🇸 USA |